(Q43745670)

26 November 2017

Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease (English)

1 reference

26 November 2017

S G Lindquist

1

1 reference

26 November 2017

M Duno

2

1 reference

26 November 2017

M Batbayli

3

1 reference

26 November 2017

A Puschmann

4

1 reference

26 November 2017

H Braendgaard

5

1 reference

26 November 2017

S Mardosiene

6

1 reference

26 November 2017

K Svenstrup

7

1 reference

26 November 2017

L H Pinborg

8

1 reference

26 November 2017

K Vestergaard

9

1 reference

26 November 2017

L E Hjermind

10

1 reference

26 November 2017

J Stokholm

11

1 reference

26 November 2017

B B Andersen

12

1 reference

26 November 2017

P Johannsen

13

1 reference

26 November 2017

J E Nielsen

14

1 reference

26 November 2017

4 July 2012

1 reference

26 November 2017

1 reference

26 November 2017

83

1 reference

26 November 2017

3

1 reference

26 November 2017

279-283

1 reference

The prevalence of frontotemporal dementia

26 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Ataxin-2 repeat-length variation and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0004.2012.01903.X

10.1111/J.1399-0004.2012.01903.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference